Advanced search
Publication Cover
Modern Rheumatology Volume 21, 2011 - Issue 6
Journal homepage
59
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Etanercept in the treatment of disease-modifying anti-rheumatic drug (DMARD)-refractory polyarticular course juvenile idiopathic arthritis: experience from Japanese clinical trials

Masaaki MoriYokohama City University School of Medicine, Yokohama, Japan;Department of Pediatrics, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama 232-0024, JapanCorrespondence[email protected]
,
Syuji TakeiKagoshima University School of Medicine, Kagoshima, Japan
,
Tomoyuki ImagawaYokohama City University School of Medicine, Yokohama, Japan
,
Hiroyuki ImanakaKagoshima University School of Medicine, Kagoshima, Japan
,
Yasuhito NeromeKagoshima University School of Medicine, Kagoshima, Japan
,
Rumiko KurosawaYokohama City University School of Medicine, Yokohama, Japan
,
Yoshifumi KawanoKagoshima University School of Medicine, Kagoshima, Japan
,
Shumpei YokotaYokohama City University School of Medicine, Yokohama, Japan
,
Noriko SugiyamaPfizer Inc, Tokyo, Japan
,
Hirotoshi YuasaPfizer Inc, Tokyo, Japan
,
Tracey FletcherPfizer Inc, Collegeville, PA, USA
&
Joseph S. WajdulaPfizer Inc, Collegeville, PA, USA
 show all
Pages 572-578 | Received 14 Jan 2011, Accepted 18 Mar 2011, Published online: 02 Jan 2014

References

  • Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: sec-ond revision, Edmonton, 2001. J Rheumatol. 2004;31(2):390–2.
  • Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. 2008;58(1):15–25.
  • Lovell DJ, Giannini EH, Reiff A, Cawkwell GD, Silverman ED, Nocton JJ, et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. N Engl J Med. 2000;342(11):763–9.
  • Prince FH, Twilt M, Jansen-Wijngaarden NC, van Suijlekom-Smit LW. Effectiveness of a once weekly double dose of eta-nercept in patients with juvenile idiopathic arthritis: a clinical study. Ann Rheum Dis. 2007;66(5):704–5.
  • Henrickson M, Reiff A. Prolonged efficacy of etanercept in refractory enthesitis-related arthritis. J Rheumatol. 2004;31(10): 2055–61.
  • Lahdenne P, Vahasalo P, Honkanen V. Infliximab or etanercept in the treatment of children with refractory juvenile idiopathic arthritis: an open label study. Ann Rheum Dis. 2003;62(3):245–7.
  • Prince FH, Twilt M, ten Cate R, van Rossum MA, Armbrust W, Hoppenreijs EP, et al. Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register. Ann Rheum Dis. 2009;68(5):635–41.
  • Lovell DJ, Reiff A, Jones OY, Schneider R, Nocton J, Stein LD, et al. Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis. Arthritis Rheum. 2006;54(6):1987–94.
  • Lovell DJ, Reiff A, Ilowite NT, Wallace CA, Chon Y, Lin SL, et al. Safety and efficacy of up to eight years of continuous eta-nercept therapy in patients with juvenile rheumatoid arthritis. Arthritis Rheum. 2008;58(5):1496–504.
  • Lovell DJ, Giannini EH, Reiff A, Jones OY, Schneider R, Olson JC, et al. Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treat-ment trial. Arthritis Rheum. 2003;48(1):218–26.
  • Giannini EH, Ilowite NT, Lovell DJ, Wallace CA, Rabinovich CE, Reiff A, et al. Long-term safety and effectiveness of eta-nercept in children with selected categories of juvenile idiopathic arthritis. Arthritis Rheum. 2009;60(9):2794–804.
  • Brewer EJ Jr, Bass J, Baum J, Cassidy JT, Fink C, Jacobs J, et al. Current proposed revision of JRA Criteria. JRA Criteria Sub-committee of the Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Section of The Arthritis Founda-tion. Arthritis Rheum. 1977;20(2 Suppl):195–9.
  • Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum. 1997;40(7):1202–9.
  • Mori M, Naruto T, Imagawa T, Murata T, Takei S, Tomiita M, et al. Methotrexate for the treatment of juvenile idiopathic arthritis: process to approval for JIA indication in Japan. Mod Rheumatol. 2009;19(1):1–11.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.